Project Grant R43DC021397

Award Date 8/10/23
Completion Date 7/31/24
Dollars Obligated $275K
Federal Grant Program
93.173
Assistance Type
Project Grant
Place of Performance
Pennsylvania, USA
Similar Awards
This Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the Research Related to Deafness and Communication Disorders Federal Grant Program (CFDA 93.173), provides $304,723 to Qualia Oto, Inc. to assess the viability of robotic-assisted, shape-conforming cochlear implant (CI) electrode arrays. The goal is to develop a new solution for achieving atraumatic cochlear implantation and optimal electrode positioning simultaneously. The project...
This Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), provides $306,073 to Iotamotion, Inc. to develop a navigation-based cochlear implant insertion system. The goal is to optimize electrode array insertion trajectories to improve short and long-term hearing outcomes for cochlear implant patients by enhancing structural preservation of the cochlea. The...
This Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the federal Research Related to Deafness and Communication Disorders Program (CFDA 93.173), will support the development and assessment of shape-adaptive cochlear implant (CI) electrode arrays. The $277,057 award to Qualia Oto, Inc. aims to address the long-standing challenge of achieving both atraumatic insertion and optimal electrode positioning during cochlear implantation. The...
This Project Grant award of $713,170 from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), will fund the development and validation of a Multimodality Micro-Optical Coherence Tomography (MM-MOCT) technology. This innovative imaging system will obtain high-resolution structural and metabolic information about the critical sensorineural cells and nerve fibers in the human cochlea....
The National Science Foundation (NSF) awarded a $649,810 Project Grant under its NSF Technology, Innovation, and Partnerships (CFDA 47.084) program to Carnegie Mellon University (CMU). The grant, with a term from February 15, 2024 to January 31, 2025, funds a convergence research project to develop flexible thin-film distributed strain sensor arrays for cochlear implants (CIs). The goal is to improve the safety and outcomes of minimally-invasive CI surgeries by enabling deformable medical...
The National Institute on Deafness and Other Communication Disorders (NIDCD) awarded a $275,371 Project Grant (CFDA 93.173) to Auricle Health Inc. to develop an extracochlear device to restore hearing for patients with sensorineural hearing loss (SNHL). The funding will support refinement of the electrode design, demonstration of electrical stimulation of the cochlear nerve in animal models, and evaluation of the long-term safety and durability of the implant. This project aims to create a...
Qualia Oto, Inc. was awarded a $233,928 Project Grant from the National Science Foundation to develop matrix-addressed, thin-film cochlear implant electrode arrays. The NSF funding supports a Small Business Technology Transfer Phase I project under the Technology, Innovation, and Partnerships program. The award will enable Qualia Oto to establish the feasibility of a novel circuit design fabricated on a thin-film platform using standard manufacturing equipment. Prototypes will undergo electrical...
This federal Project Grant award from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866) provides $783,083 to study the effectiveness of cochlear implants and hearing aids for older adults with age-related hearing loss and cognitive impairment. The study aims to compare the real-world impacts of cochlear implants versus hearing aids on auditory function, cognitive performance, social interaction, and psychosocial well-being in this population. The University...
This federal Project Grant award of $1,403,696, provided by the National Institute on Deafness and Other Communication Disorders (NIDCD) under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), aims to use optical coherence tomography (OCT) imaging to visualize the fluid compartments of the human inner ear. The primary objectives are to: 1) Characterize the normal endolymph-to-perilymph ratio in control subjects undergoing mastoid surgery, and 2) Compare the...
This Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), will fund the development of a new, ultra-low-fouling coating technology by Zwicoat Materials Innovations, LLC (ZCMI). The project aims to establish the technical feasibility of applying ZCMI's patented zwitterionic coating to two existing medical implants: cochlear implant (CI) electrode arrays and...

DETERMINING RELIABILITY AND EFFICACY OF INTRAOPERATIVE SENSORS TO REDUCE STRUCTURAL DAMAGE DURING COCHLEAR IMPLANTATION - PROJECT SUMMARY HL IS A LEADING CAUSE OF DISABILITY WORLDWIDE, RESPONSIBLE FOR AN ESTIMATED $981B IN GLOBAL COSTS. WHEN ACOUSTIC AMPLIFICATION OF HEARING AIDS IS NO LONGER AN EFFECTIVE TREATMENT, PATIENTS CAN RECEIVE A COCHLEAR IMPLANT (CI). CURRENTLY, THE SURGEON THREADS THE ELECTRODE ARRAY INTO THE SPIRAL COCHLEA, RISKING STRUCTURAL DAMAGE THAT DESTROYS RESIDUAL ACOUSTIC HEARING AND IMPACTS OVERALL HEARING OUTCOMES. CONSEQUENTLY, ADOPTION RATES REMAIN EXTREMELY LOW: 5% OF THE ELIGIBLE POPULATION IN THE US. ADVANCED OPTRONICS (AO) IS DEVELOPING A NOVEL SURGEON GUIDANCE SYSTEM USING A MICROELECTROMECHANICAL SYSTEM (MEMS) SENSOR ARRAY THAT WILL BE SEAMLESSLY INTEGRATED WITH EXISTING CI ELECTRODE ARRAY DESIGNS TO DETECT BENDING AND FORCES ACTING ON THE ARRAY TO WARN SURGEONS OF POTENTIAL RISKS. USING ADVANCED POLYMER MICROFABRICATION TECHNIQUES, AO HAS PRODUCED ULTRA-THIN AND FLEXIBLE SENSORS THAT CAN BE INCORPORATED INTO CI ELECTRODES WITH MINIMAL IMPACT ON THE CI ELECTRODE SIZE OR MECHANICS. THIS PHASE I PROPOSAL WILL DEMONSTRATE THE FEASIBILITY OF THE SYSTEM FROM A FABRICATION, USABILITY, AND REGULATORY PERSPECTIVE. THE PHASE I RESULTS WILL PAVE THE WAY FOR CLINICAL TRANSLATION DURING PHASE II. THE SPECIFIC AIMS FOR THE PHASE I PROJECT ARE: SPECIFIC AIM 1: DETERMINING SENSOR RELIABILITY WITH A COCHLEAR IMPLANT ELECTRODE: THE COMPLETE SYSTEM (CI + SENSOR) WILL BE ITERATIVELY IMPROVED FOR ROBUSTNESS AND RELIABILITY TO MAXIMIZE TWO KEY METRICS: 1. MEASUREMENT RELIABILITY, AND 2. ATTACHMENT ROBUSTNESS. SPECIFIC AIM 2: DEMONSTRATING SENSOR EFFECTIVENESS TO IMPROVE SURGEON TECHNIQUE: THE SYSTEM'S EFFICACY WILL BE VALIDATED VIA SURGEON INSERTION IN 3D PRINTED COCHLEAR MODELS. SURGEONS WILL SYSTEMATICALLY VARY INSERTION TECHNIQUE AND DATA COLLECTED IN THESE TRIALS WILL BE EVALUATED TO SHOW THAT REAL-TIME FEEDBACK ALLOWS SURGEONS TO MINIMIZE INSERTION FORCES. SPECIFIC AIM 3: DETERMINING REGULATORY PATHWAY AND REQUIREMENTS: A DETAILED REGULATORY PROPOSAL WILL BE PREPARED TO COVER INTENDED USE, REGULATORY DESCRIPTIONS OF HARDWARE AND SOFTWARE COMPONENTS, AND STUDIES TO SUPPORT SAFETY AND EFFECTIVENESS. A PRE-SUBMISSION BRIEFING DOCUMENT WILL BE PREPARED FOR AN EARLY AND COMPREHENSIVE FDA DISCUSSION ON PRODUCT DEVELOPMENT AND REGISTRATION STRATEGIES.

Posted 8/10/23, 12:00 AM